Sfoglia per Autore
Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests
2008 A. Tripodi, L.A. Ramenghi, V. Chantarangkul, A.M. De Carli, M. Clerici, M. Groppo, F. Mosca, P.M. Mannucci
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis
2009 A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell'Era, M. Clerici, R. de Franchis, M. Colombo, P.M. Mannucci
Association between thrombin generation and bleeding severity in 41 patients with coagulation factor VII deficiency
2013 L.A. Lotta, S.M. Siboni, L. Lemma, M. Clerici, M. Menegatti, F. Peyvandi
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
2014 A. Tripodi, A.L. Fracanzani, M. Primignani, V. Chantarangkul, M. Clerici, P.M. Mannucci, F. Peyvandi, C. Bertelli, L. Valenti, S. Fargion
Hemostatic abnormalities in patients with Ehlers–Danlos syndrome
2018 A. Artoni, A. Bassotti, M. Abbattista, B. Marinelli, A. Lecchi, F. Gianniello, M. Clerici, P. Bucciarelli, S. La Marca, F. Payvandi, I. Martinelli
Thromboelastometry. Reproducibility of duplicate measurement performed by the RoTem® device
2018 E. Scalambrino, L. Padovan, M. Clerici, V. Chantarangkul, S. Biliou, F. Peyvandi, A. Tripodi
Thrombin generation assay for testing hemostatic effect of factor VIII concentrates in patients with hemophilia A and inhibitors: In vitro results from the PredicTGA study
2019 A. Tripodi, V. Chantarangkul, M. Clerici, R. Bader, M.B. Anzoletti, F. Peyvandi, E.M. Santagostino
Consensus statements on vaccination in patients with haemophilia—results from the italian haemophilia and vaccinations (Heva) project
2019 E. Santagostino, A. Riva, S. Cesaro, S. Esposito, D. Matino, R.I. Mazzucchelli, A.C. Molinari, R. Mura, L.D. Notarangelo, A. Tagliaferri, G. Di Minno, M. Clerici
Body mass index reduction improves the baseline procoagulant imbalance of obese subjects
2019 A. Tripodi, M. Primignani, S. Badiali, F. de Ruberto, P. Granelli, G. Tosetti, M. Clerici, L. Padovan, V. Chantarangkul, E. Scalambrino, F. Peyvandi
Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma
2020 A. Tripodi, V. Chantarangkul, C. Novembrino, E. Scalambrino, M. Boscolo-Anzoletti, M. Clerici, F. Rossi, F. Peyvandi
Procoagulant imbalance in preterm neonates detected by thrombin generation procedures
2020 A. Tripodi, G. Raffaeli, E. Scalambrino, L. Padovan, M. Clerici, V. Chantarangkul, G. Cavallaro, F. Peyvandi, F. Mosca, S. Ghirardello
Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study
2020 E. Scalambrino, L. Padovan, V. Chantarangkul, M. Clerici, A. Artoni, F. Peyvandi, A. Tripodi
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
2021 S. Bonato, A. Artoni, A. Lecchi, G. Schwarz, S. La Marca, L. Padovan, M. Clerici, C. Guadino, G.P. Comi, A. Tripodi, F. Peyvandi
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels
2021 M. Capecchi, E. Scalambrino, S. Griffini, E. Grovetti, M. Clerici, G. Merati, V. Chantarangkul, M. Cugno, F. Peyvandi, A. Tripodi
Procoagulant imbalance in Klinefelter syndrome assessed by thrombin generation assay and whole blood thromboelastometry
2021 R. Indirli, E. Ferrante, E. Scalambrino, E. Profka, M. Clerici, T. Lettera, A.L. Serban, W. Vena, A. Pizzocaro, M. Bonomi, B. Cangiano, G. Carosi, G. Mazziotti, L. Persani, A. Lania, M. Arosio, F. Peyvandi, G. Mantovani, A. Tripodi
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection
2021 A. Tripodi, E. Scalambrino, V. Chantarangkul, O. Paoletti, M. Clerici, C. Novembrino, M. Boscolo-Anzoletti, F. Peyvandi, S. Testa
No changes of parameters nor coagulation activation in healthy subjects vaccinated for {SARS}-Cov-2
2021 F. Payvandi, E. Scalambrino, M. Clerici, A. Lecchi, N. Revelli, R. Palla, R. Gualtierotti, D. Prati, A. Tripodi
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge
2021 A. Tripodi, S.C. Rossi, M. Clerici, G. Merati, E. Scalambrino, I. Mancini, L. Baronciani, M. Boscarino, V. Monzani, F. Peyvandi
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi
Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations
2023 A. Tripodi, E. Scalambrino, M. Clerici, V. Chantarangkul, F. Peyvandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile